5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl Carboxamides As Jak Inhibitors

A novel compound able to inhibit JAK is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune dis...

Full description

Saved in:
Bibliographic Details
Main Authors KURT SMITS KOE, MARIE MENET CHRISTEL JEANNE
Format Patent
LanguageEnglish
Published 07.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel compound able to inhibit JAK is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6.
Bibliography:Application Number: CN201410408911